Related Experiment Video
Updated: Sep 29, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
Peptidic inhibitors of the hepatitis C virus serine protease within non-structural protein 3
1Schering-Plough Research Institute, 2015 Galloping Hill Road, Kenilworth, NJ 07033, USA. thierry.fischmann@spcorp.com
Abstract:
New treatments for HCV (Hepatitis C virus) infections are likely to arise from inhibition of the essential, virally-encoded enzymes. These targets include the serine protease required for processing of the HCV polyprotein. The protease constitutes one functional domain of the bifunctional HCV NS3 (non-structural protein 3). Here, insights regarding the NS3 structure and recently synthesized NS3 inhibitors are reviewed. Interestingly, many NS3 protease inhibitors have taken advantage of an unusual product inhibition by N-terminal products of cleavage at the polyprotein processing sites.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Inhibitors of Virion Maturation and Assembly
Hepatitis
Inhibitors Of Virion Release
Antiviral Nucleoside Inhibitors
Protein and Protein Structure

